The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Read before the Boston Society for Medical Observation, November 6, 1893. Select the format you want to export the citation of this publication.

Abstract: Adenoid hypertrophy is one of the most common upper respiratory tract disorders during childhood, leading to a range of symptoms such as nasal congestion, mouth breathing and obstructive ...

By humming a few minutes every day, you can exercise your nose and strengthen your inferior turbinate function. It helps remove allergens and irritants from the nasal passages, minimizes turbinate ...